REINACH, Switzerland, December 14 /PRNewswire-FirstCall/ -- As reported in September, Arpida Ltd. (SWX: ARPN) had a significant presence at this year's Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). A webcast of a CME accredited symposium at ICAAC, that was supported through an educational grant by Arpida, is available online at http://www.IDCME.org.
The symposium is entitled "Treatment of Methicillin-resistant Staphylococcus aureus and Other Resistant Infections: An Expert Debate". In it distinguished speakers such as John G. Bartlett, MD, Louis B. Rice, MD, Dennis L. Stevens, PhD, MD, Gregory J. Moran, MD, FACEP and Robert C. Moellering, Jr., MD, MACP discuss the latest trends in their field. Topics include the increasing incidence of MRSA infections both in the healthcare setting and in the community, existing and emerging treatment options, as well as the changing landscape of bacterial resistance.
ICAAC is recognised as a premier global meeting for clinicians, researchers and scientists in the field of infectious diseases. In addition to the support of the CME symposium Arpida's participation comprised an exhibition booth which generated significant interest among the conference attendees as well as presentation of a total of 32 posters: 19 on the late-stage investigational antibiotic iclaprim and a total of 13 on AR-709 and AR-2474.
About the CME symposium
This CME (Continuing Medical Education) symposium should be seen as an
educational activity, aimed primarily at healthcare professionals. Arpida
Ltd. supported this educational activity through an unrestricted
educational grant. The content and views presented in this educational
activity are those of the authors and do not necessarily reflect those of
Arpida Ltd., or the organisers. This material is prepared based upon a
review of multiple sources of information, but it is not exhaustive of the
Copyright©2007 PR Newswire.
All rights reserved